Position in ROIV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,507,362,901
+$71,718,306 QoQ
Shares Held
42,592,905
-17.8% QoQ
Ownership
5.90%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#3
of 489 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 86%
Shared 4%
None 11%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,716,934,888 across 523 Biotechnology names. ROIV ranks #3 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
This page
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in ROIV
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,507,362,901 | 42,592,905 | Shares | Defined | 2026-08-13 | |
| 2026-06-30 | $1,440,138,930 | 40,693,386 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,435,644,595 | 51,828,325 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,266,402,294 | 58,359,553 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $670,604,822 | 44,322,857 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $503,700,992 | 44,693,966 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $362,500,994 | 35,926,759 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $409,496,309 | 34,615,073 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $342,438,001 | 29,674,004 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $310,019,564 | 29,330,139 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $375,598,176 | 35,635,501 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $246,240,700 | 21,927,044 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $225,559,848 | 19,311,631 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $130,906,092 | 12,986,716 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $23,440,824 | 3,176,264 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,752,584 | 344,504 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $132,544 | 41,164 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $106,560 | 26,182 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $1,546 | 313 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $7,458 | 740 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||